These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9833904)

  • 21. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver].
    Hige S
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
    Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
    Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment.
    Koizumi K; Enomoto N; Kurosaki M; Murakami T; Izumi N; Marumo F; Sato C
    Hepatology; 1995 Jul; 22(1):30-5. PubMed ID: 7541387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
    Martinot M; Marcellin P; Boyer N; Detmer J; Pouteau M; Castelnau C; Degott C; Aupérin A; Collins M; Kolberg J; Wilber J; Benhamou JP; Erlinger S
    Ann Intern Med; 1997 Jun; 126(11):874-81. PubMed ID: 9163288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease.
    Anand BS; Velez M
    World J Gastroenterol; 2004 Aug; 10(16):2409-11. PubMed ID: 15285030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with recombinant interferon-alpha 2a for patients with chronic hepatitis C: predictive factors for biochemical and virologic response. Osaka Liver Disease Study Group.
    Hagiwara H; Hayashi N; Kasahara A; Oshita M; Katayama K; Kato M; Masuzawa M; Fusamoto H; Sakurai M; Kamada T
    Scand J Gastroenterol; 1996 Oct; 31(10):1021-6. PubMed ID: 8898424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.
    Rostaing L; Izopet J; Cisterne JM; Arnaud C; Duffaut M; Rumeau JL; Puel J; Durand D
    Transplantation; 1998 Apr; 65(7):930-6. PubMed ID: 9565097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.
    Adinolfi LE; Utili R; Andreana A; Tripodi MF; Marracino M; Gambardella M; Giordano M; Ruggiero G
    Dig Dis Sci; 2001 Aug; 46(8):1677-83. PubMed ID: 11508667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier.
    Nakazawa T; Kato N; Ootsuyama Y; Sekiya H; Fujioka T; Shibuya A; Shimotohno K
    Int J Cancer; 1994 Jan; 56(2):204-7. PubMed ID: 8314302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus.
    Kato T; Mizokami M; Nakano T; Orito E; Ohba K; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Fujita K; Yasuda K; Iino S
    J Med Virol; 1998 Jun; 55(2):109-17. PubMed ID: 9598930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the hypervariable region of hepatitis C virus genomes in plasma and liver.
    Sakamoto N; Enomoto N; Kurosaki M; Asahina Y; Maekawa S; Koizumi K; Sakuma I; Murakami T; Marumo F; Sato C
    J Med Virol; 1995 May; 46(1):7-11. PubMed ID: 7623010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C.
    Lee YS; Yoon SK; Chung ES; Bae SH; Choi JY; Han JY; Chung KW; Sun HS; Kim BS; Kim BK
    J Korean Med Sci; 2001 Oct; 16(5):585-91. PubMed ID: 11641527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation.
    Sánchez-Fueyo A; Giménez-Barcons M; Puig-Basagoiti F; Rimola A; Sánchez-Tapias JM; Sáiz JC; Rodés J
    J Med Virol; 2001 Oct; 65(2):266-75. PubMed ID: 11536232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.
    McGuinness PH; Bishop GA; Painter DM; Chan R; McCaughan GW
    Hepatology; 1996 Apr; 23(4):676-87. PubMed ID: 8666317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C viral load, genotype and histological severity in patients with bleeding disorders.
    Ahmed MM; Mutimer DJ; Martin B; Elias E; Wilde JT
    Haemophilia; 1999 Jan; 5(1):49-55. PubMed ID: 10215947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reaction.
    Inokuchi K; Nakata K; Hamasaki K; Daikoku M; Nakao K; Kato Y; Yatsuhashi H; Koga M; Yano M; Nagataki S
    J Hepatol; 1996 Mar; 24(3):258-64. PubMed ID: 8778190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between diversity of hepatitis C virus quasispecies and viremia, activity of liver disease and response to interferon therapy].
    Tang X; Qian K; Yuan X; Johnson YN
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):128-31. PubMed ID: 12196822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
    Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
    Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.